DOCSLIB.ORG

Software and Techniques for Bio-Molecular Modelling

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Software and Techniques for Bio-Molecular Modelling Azat Mukhametov Published by Austin Publications LLC Published Date: December 01, 2016 Online Edition available at http://austinpublishinggroup.com/ebooks For reprints, please contact us at [email protected] All book chapters are Open Access distributed under the Creative Commons Attribution 4.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of the publication. Upon publication of the eBook, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work, identifying the original source. Statements and opinions expressed in the book are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Software and Techniques for Bio-Molecular Modelling | www.austinpublishinggroup.com/ebooks 1 Copyright Mukhametov A.This book chapter is open access distributed under the Creative Commons Attribution 4.0 International License, which allows users to download, copy and build upon published articles even for com- mercial purposes, as long as the author and publisher are properly credited. We consider to publish more books on the topics of drug design, molecular modelling, and structure-activity relationships. Those, wishing to contribute a chapter or article please contact this Book’s Editor by e-mail: [email protected] Software and Techniques for Bio-Molecular Modelling | www.austinpublishinggroup.com/ebooks 2 Copyright Mukhametov A.This book chapter is open access distributed under the Creative Commons Attribution 4.0 International License, which allows users to download, copy and build upon published articles even for com- mercial purposes, as long as the author and publisher are properly credited. Table of Contents Preface 5 Software 1.GROMPALA: a membrane-implicit modelling method to screen lipid- 8 interacting molecules. Steinhauer S, Crowet JM, Brasseur R and Lins L 2. AtlasCBS: a graphic tool to map the content of structure-activity databases. 19 Abad-Zapatero C 3. Modeller: an application for homology modeling. Singh R and Gaur P 38 Techniques 4. Protein structure prediction using molecular homology modelling. Barbosa 48 LCB and Carrijo RS 5. Structure, shape and electrostatic based virtual screening to discover small 58 molecule therapeutics. Parkesh R, Bhutani I and Madathil R 6. Introduction to the molecular dynamics of biomolecules. Morton-Blake DA 75 7. GPU accelerated molecular dynamics simulations for predition of protien- 90 Chong WL, Gautam V, Zain SM, Noorsaadah AR and Lee VS peptide and protein-protein binding affinity. 8. Knowledge formalization and high-throughput data visualization using 107 signaling network maps. Kondratova M, Barillot E, Zinovyev A and Kuperstein I Case Studies 9. Neuro-ligands optimization using molecular modeling. Chaturvedi S and 131 Mishra Anil K 10. Rational drug discovery: virtual screening of Den-2 non-competitive 147 inhibitors. Heh CH, Othman R, Yusof R and Rahman NA Software and Techniques for Bio-Molecular Modelling | www.austinpublishinggroup.com/ebooks 3 11. Comparative evaluation of docking programs: a case study with small 156 peptidic ligands. Kumar M, Tiwari P and Kaur P 12. Protein interaction study of novel mutants of human Hsp70 and Ad5 motif 171 (PNLVP). Elengoe A and Hamdan S 183 antagonist. Divakar S, Hariharan S and Ramanathan M 13. Structure based drug design in identification of novel androgen receptor 14. Hepatitis C viral polymerase inhibition using directly acting antivirals: a 197 computational approach. Elfiky AA, Gawad WA and Elshemey WM. 209 Muchtaridi 15. Application of structure and ligand-based drug design for finding lead compounds16. Molecular from dynamics natural product of E. source:coli Undecaprenyl case of influenza Diphosphate targeted. Synthase: 222 asymmetry in a homodimer. Newhouse EI, Alam M and Mukhametov A 17. Molecular dynamics simulations and molecular docking approaches in 237 Torabizadeh H SponsorsEndoinulinase and Advertisements chemical modification. Venture Pharmaceuticals Ltd 247 Software and Techniques for Bio-Molecular Modelling | www.austinpublishinggroup.com/ebooks 4 Preface The purpose of this book is to introduce new researchers into the field of Bio-Molecular Modelling. The field lays at intersection of such disciplines as Biology, Chemistry, Physics, and Computer Sciences. It is not surprising that researchers with respective backgrounds are attracted. Historically, modelling techniques applied to discovery and development of new bio-active compounds, were ligand-based. These are methods of quantitative structure-activity (QSAR) and structure-property (QSPR) studies. To date, these methods include multiple techniques. Linear regression analysis, support vector machines, random forest, naive Bayes, and artificial neural networks are just some examples that utilize massive mathematical apparatus. With introduction of protein structure determination methods and exponential increase in computer power, structure-based methods of designing bio-active compounds became also available. Modelling techniques got fast developing being applied to the challenges of life sciences (pharmaceutical, bio-technology, and agricultural sciences). These are search for biologically active molecules with targeted properties, development of special purpose proteins for industry, and fundamental studies of biological processes at molecular level. Bio-Molecular Modelling includes various sub-fields. Bio-informatics lays at intersection of biology and computer sciences. Chemo-informatics utilizes computer sciences to operate with chemical structures. Theoretical bio-physics applies methods of computational physics to biology challenges. This way the fields of Bio-Molecular Modelling develop extensively and intensively in various directions. Nova days Bio-Molecular Modelling includes multiple techniques. Methods of homology modelling let model three-dimensional structures of proteins based on the sequence of target protein and x-ray structural data of the template protein(s). Automated computational docking approaches make it possible to study the way small molecules may interact with bio-molecular targets. Being utilized to large library of ligands, it gets name of virtual screening. Pharmacophore modelling techniques let make pharmacophore models based on the structures of ligands Softwareor protein-ligand and Techniques complexes for Bio-Molecular for following Modelling pharmacophore-based | www.austinpublishinggroup.com/ebooks virtual screening of small5 Copyright Mukhametov A.This book chapter is open access distributed under the Creative Commons Attribution 4.0 International License, which allows users to download, copy and build upon published articles even for com- mercial purposes, as long as the author and publisher are properly credited. molecular ligands. Techniques of Molecular Dynamics simulations let computationally model dynamics of bio-molecules in native environment. Atomic-level interactions between parts of bio-molecules or their fragments can be studied with Quantum Chemistry approaches. Bio- Informatics approaches let understand interactions between bio-molecular targets and select key ones for Bio-Molecular Modelling. The listed are not all topics and fields of Bio-Molecular Modelling. However, these are the approaches which formed ground for future developments. Multiple methods and approaches are arising currently. Structurally, this Book “Software and Techniques for Bio-Molecular Modelling” consists of three parts: “Software”, “Techniques”, and “Case Studies”. Modern and powerful software is a key component for Bio-Molecular Modelling. These are complex packages, small applications, as desktop as network based. Databases can also be considered with software. “Software” – includes small chapters on software packages, and algorithms, available as on open-source as on commercial basis. Each article gives information on software, algorithms involved, purposes, pros and cons, license terms, references. Chapters on special-purpose applications are included. These are GROMPALA (a membrane- implicit modelling method to screen lipid-interacting molecules) by Dr. Laurence Lins; AtlasCBS (a graphic tool to map the content of structure-activity databases) by Dr. Cele Abad-Zapatero; and Modeller (an application for homology modelling) by Dr. Raghvendra Singh. Many techniques for Bio-Molecular Modelling, are included into the “Techniques” part of the Book. Each chapter includes introduction, background, technique description, references. All of the techniques described have been successfully applied to bio-molecular challenges by scientists in the field. These are the technique for Homology Modelling: Protein structure prediction using molecular homology modelling, by Dr. Luiz Carlos Bertucci Barbosa. Technique for Virtual Screening: Structure, shape and electrostatic based virtual screening to discover small molecule therapeutics, by Dr. Raman Parkesh. Techniques for Molecular Dynamics Simulations:
Recommended publications
  • MODELLER 10.1 Manual

    MODELLER 10.1 Manual

    MODELLER A Program for Protein Structure Modeling Release 10.1, r12156 Andrej Saliˇ with help from Ben Webb, M.S. Madhusudhan, Min-Yi Shen, Guangqiang Dong, Marc A. Martı-Renom, Narayanan Eswar, Frank Alber, Maya Topf, Baldomero Oliva, Andr´as Fiser, Roberto S´anchez, Bozidar Yerkovich, Azat Badretdinov, Francisco Melo, John P. Overington, and Eric Feyfant email: modeller-care AT salilab.org URL https://salilab.org/modeller/ 2021/03/12 ii Contents Copyright notice xxi Acknowledgments xxv 1 Introduction 1 1.1 What is Modeller?............................................. 1 1.2 Modeller bibliography....................................... .... 2 1.3 Obtainingandinstallingtheprogram. .................... 3 1.4 Bugreports...................................... ............ 4 1.5 Method for comparative protein structure modeling by Modeller ................... 5 1.6 Using Modeller forcomparativemodeling. ... 8 1.6.1 Preparinginputfiles . ............. 8 1.6.2 Running Modeller ......................................... 9 2 Automated comparative modeling with AutoModel 11 2.1 Simpleusage ..................................... ............ 11 2.2 Moreadvancedusage............................... .............. 12 2.2.1 Including water molecules, HETATM residues, and hydrogenatoms .............. 12 2.2.2 Changing the default optimization and refinement protocol ................... 14 2.2.3 Getting a very fast and approximate model . ................. 14 2.2.4 Building a model from multiple templates . .................. 15 2.2.5 Buildinganallhydrogenmodel
  • Latest Stable Copy and Install It With: Chmod+X Chimera- *.Bin&&./Chimera- *.Bin

    Latest Stable Copy and Install It With: Chmod+X Chimera- *.Bin&&./Chimera- *.Bin

    Tangram Suite Documentation Release 0.0.8 InsiliChem Mar 26, 2019 General instructions 1 What is Tangram Suite 3 2 How to install Tangram Suite5 3 General usage 7 4 FAQ & Known issues 9 5 List of Tans 11 6 Tangram BondOrder 13 7 Tangram QMSetup 15 8 Tangram DummyAtoms 17 9 Tangram GAUDIView 19 10 Tangram MMSetup 21 11 Tangram NCIPlot 23 12 Tangram NormalModes 25 13 Tangram OrbiTraj 27 14 Tangram PLIP 29 15 Tangram PoPMuSiCGUI 31 16 Tangram PropKaGUI 33 17 Tangram ReVina 35 18 Tangram SubAlign 37 19 Tangram TalaDraw 39 i ii Tangram Suite Documentation, Release 0.0.8 It’s composed of several independent graphical interfaces and commands for UCSF Chimera. General instructions 1 Tangram Suite Documentation, Release 0.0.8 2 General instructions CHAPTER 1 What is Tangram Suite In progress 3 Tangram Suite Documentation, Release 0.0.8 4 Chapter 1. What is Tangram Suite CHAPTER 2 How to install Tangram Suite 2.1 Install the full Tangram Suite (recommended) 1 - If you don’t have UCSF Chimera installed, download the latest stable copy and install it with: chmod+x chimera- *.bin&&./chimera- *.bin 2 - Download the latest installer from the releases page (Linux and MacOS only) and run it with: bash tangram-*.sh 2.2 Using the conda meta-package Instead of using the Bash installer, you can use conda (if you are already using it) to create a new environment with the tangram metapackage, which will handle all the dependencies. While in alpha, both insilichem channels are needed (the main one and also the dev label): conda create-n tangram-c insilichem/label/dev-c insilichem-c omnia-c rdkit-c ,!conda-forge tangram 2.3 Updating extensions Each extension will check if there’s a new release available every time you launch it.
  • MODELLER 10.0 Manual

    MODELLER 10.0 Manual

    MODELLER A Program for Protein Structure Modeling Release 10.0, r12005 Andrej Saliˇ with help from Ben Webb, M.S. Madhusudhan, Min-Yi Shen, Guangqiang Dong, Marc A. Martı-Renom, Narayanan Eswar, Frank Alber, Maya Topf, Baldomero Oliva, Andr´as Fiser, Roberto S´anchez, Bozidar Yerkovich, Azat Badretdinov, Francisco Melo, John P. Overington, and Eric Feyfant email: modeller-care AT salilab.org URL https://salilab.org/modeller/ 2021/01/25 ii Contents Copyright notice xxi Acknowledgments xxv 1 Introduction 1 1.1 What is Modeller?............................................. 1 1.2 Modeller bibliography....................................... .... 2 1.3 Obtainingandinstallingtheprogram. .................... 3 1.4 Bugreports...................................... ............ 4 1.5 Method for comparative protein structure modeling by Modeller ................... 5 1.6 Using Modeller forcomparativemodeling. ... 8 1.6.1 Preparinginputfiles . ............. 8 1.6.2 Running Modeller ......................................... 9 2 Automated comparative modeling with AutoModel 11 2.1 Simpleusage ..................................... ............ 11 2.2 Moreadvancedusage............................... .............. 12 2.2.1 Including water molecules, HETATM residues, and hydrogenatoms .............. 12 2.2.2 Changing the default optimization and refinement protocol ................... 14 2.2.3 Getting a very fast and approximate model . ................. 14 2.2.4 Building a model from multiple templates . .................. 15 2.2.5 Buildinganallhydrogenmodel
  • GROMACS: Fast, Flexible, and Free

    GROMACS: Fast, Flexible, and Free

    GROMACS: Fast, Flexible, and Free DAVID VAN DER SPOEL,1 ERIK LINDAHL,2 BERK HESS,3 GERRIT GROENHOF,4 ALAN E. MARK,4 HERMAN J. C. BERENDSEN4 1Department of Cell and Molecular Biology, Uppsala University, Husargatan 3, Box 596, S-75124 Uppsala, Sweden 2Stockholm Bioinformatics Center, SCFAB, Stockholm University, SE-10691 Stockholm, Sweden 3Max-Planck Institut fu¨r Polymerforschung, Ackermannweg 10, D-55128 Mainz, Germany 4Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 4, NL-9747 AG Groningen, The Netherlands Received 12 February 2005; Accepted 18 March 2005 DOI 10.1002/jcc.20291 Published online in Wiley InterScience (www.interscience.wiley.com). Abstract: This article describes the software suite GROMACS (Groningen MAchine for Chemical Simulation) that was developed at the University of Groningen, The Netherlands, in the early 1990s. The software, written in ANSI C, originates from a parallel hardware project, and is well suited for parallelization on processor clusters. By careful optimization of neighbor searching and of inner loop performance, GROMACS is a very fast program for molecular dynamics simulation. It does not have a force field of its own, but is compatible with GROMOS, OPLS, AMBER, and ENCAD force fields. In addition, it can handle polarizable shell models and flexible constraints. The program is versatile, as force routines can be added by the user, tabulated functions can be specified, and analyses can be easily customized. Nonequilibrium dynamics and free energy determinations are incorporated. Interfaces with popular quantum-chemical packages (MOPAC, GAMES-UK, GAUSSIAN) are provided to perform mixed MM/QM simula- tions. The package includes about 100 utility and analysis programs.
  • Secondary Structure Propensities in Peptide Folding Simulations: a Systematic Comparison of Molecular Mechanics Interaction Schemes

    Secondary Structure Propensities in Peptide Folding Simulations: a Systematic Comparison of Molecular Mechanics Interaction Schemes

    Biophysical Journal Volume 97 July 2009 599–608 599 Secondary Structure Propensities in Peptide Folding Simulations: A Systematic Comparison of Molecular Mechanics Interaction Schemes Dirk Matthes and Bert L. de Groot* Department of Theoretical and Computational Biophysics, Computational Biomolecular Dynamics Group, Max-Planck-Institute for Biophysical Chemistry, Go¨ttingen, Germany ABSTRACT We present a systematic study directed toward the secondary structure propensity and sampling behavior in peptide folding simulations with eight different molecular dynamics force-field variants in explicit solvent. We report on the combi- national result of force field, water model, and electrostatic interaction schemes and compare to available experimental charac- terization of five studied model peptides in terms of reproduced structure and dynamics. The total simulation time exceeded 18 ms and included simulations that started from both folded and extended conformations. Despite remaining sampling issues, a number of distinct trends in the folding behavior of the peptides emerged. Pronounced differences in the propensity of finding prominent secondary structure motifs in the different applied force fields suggest that problems point in particular to the balance of the relative stabilities of helical and extended conformations. INTRODUCTION Molecular dynamics (MD) simulations are routinely utilized to that study, simulations of relatively short lengths were per- study the folding dynamics of peptides and small proteins as formed and the natively folded state was used as starting well as biomolecular aggregation. The critical constituents of point, possibly biasing the results (13). such molecular mechanics studies are the validity of the under- For folding simulations, such a systematic test has not lyingphysical models together with theassumptionsofclassical been carried out so far, although with growing computer dynamics and a sufficient sampling of the conformational power several approaches toward the in silico folding space.
  • JRC QSAR Model Database

    JRC QSAR Model Database

    JRC QSAR Model Database EURL ECVAM DataBase service on ALternative Methods to animal experimentation To promote the development and uptake of alternative and advanced methods in toxicology and biomedical sciences SDF - STRUCTURE DATA FORMAT: How to create from SMILES The European Commission’s science and knowledge service Joint Research Centre Directorate F Health, Consumers & Reference Materials Chemicals Safety & Alternative Methods Unit The European Commission’s science and knowledge service Joint Research Centre EUR 28708 EN This publication is a Tutorial by the Joint Research Centre (JRC), the European Commission’s science and knowledge service. It aims to provide user support. The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication. Contact information Email: [email protected] JRC Science Hub https://ec.europa.eu/jrc JRC107492 EUR 28708 EN PDF ISBN 978-92-79-71294-4 ISSN 1831-9424 doi:10.2760/952280 Print ISBN 978-92-79-71295-1 ISSN 1018-5593 doi:10.2760/668595 Luxembourg: Publications Office of the European Union, 2017 Ispra: European Commission, 2017 © European Union, 2017 The reuse of the document is authorised, provided the source is acknowledged and the original meaning or message of the texts are not distorted. The European Commission shall not be held liable for any consequences stemming from the reuse. How to cite this document: Triebe
  • Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

    Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

    processes Review Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development Outi M. H. Salo-Ahen 1,2,* , Ida Alanko 1,2, Rajendra Bhadane 1,2 , Alexandre M. J. J. Bonvin 3,* , Rodrigo Vargas Honorato 3, Shakhawath Hossain 4 , André H. Juffer 5 , Aleksei Kabedev 4, Maija Lahtela-Kakkonen 6, Anders Støttrup Larsen 7, Eveline Lescrinier 8 , Parthiban Marimuthu 1,2 , Muhammad Usman Mirza 8 , Ghulam Mustafa 9, Ariane Nunes-Alves 10,11,* , Tatu Pantsar 6,12, Atefeh Saadabadi 1,2 , Kalaimathy Singaravelu 13 and Michiel Vanmeert 8 1 Pharmaceutical Sciences Laboratory (Pharmacy), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland; ida.alanko@abo.fi (I.A.); rajendra.bhadane@abo.fi (R.B.); parthiban.marimuthu@abo.fi (P.M.); atefeh.saadabadi@abo.fi (A.S.) 2 Structural Bioinformatics Laboratory (Biochemistry), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland 3 Faculty of Science-Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands; [email protected] 4 Swedish Drug Delivery Forum (SDDF), Department of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden; [email protected] (S.H.); [email protected] (A.K.) 5 Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7 A, FI-90014 Oulu, Finland; andre.juffer@oulu.fi 6 School of Pharmacy, University of Eastern Finland, FI-70210 Kuopio, Finland; maija.lahtela-kakkonen@uef.fi (M.L.-K.); tatu.pantsar@uef.fi
  • Quantitative Evaluation of Dissociation Mechanisms in Phenolphthalein and the Related Compounds

    Quantitative Evaluation of Dissociation Mechanisms in Phenolphthalein and the Related Compounds

    J. Comput. Chem. Jpn., Vol. 15, No. 1, pp. 13–21 (2016) ©2016 Society of Computer Chemistry, Japan Technical Paper Quantitative Evaluation of Dissociation Mechanisms in Phenolphthalein and the Related Compounds Toshihiko HANAI Health Research Foundation, Research Institute for Production Development 4F, 15 Shimogamo-morimoto-cho, Sakyo-ku, Kyoto 606-0805, Japan e-mail: [email protected] (Received: October 11, 2015; Accepted for publication: April 14, 2016; Online publication: May 6, 2016) Computational chemistry programs were evaluated as aids to teaching qualitative analytical chemistry. Compu- tational chemical calculations can predict absorption spectra, thus enabling the modeling of indicator dissociation mechanisms by different computational chemical programs using a personal computer. An updated MNDO program among 51 programs was found to be the best predictor to explain the dissociation mechanisms of isobenzofuranones and sulfonephthaleins. Unknown dissociation constants were predicted from atomic partial charges instead of Ham- mett's constants. Keywords: Quantitative analysis of dissociation mechanisms, Isobenzofuranone, Sulfonephthalein, Computational chemistry 1 Introduction the absorption wavelength and electron density changes were not well described. The dissociation mechanisms, maximum How to quantitatively teach qualitative analytical chemistry is wavelengths, and electron density maps of isobenzofuranones a very important subject for analytical chemists. Previously, a and sulfonephthaleins were, therefore, evaluated by in silico method to teach molecular interaction mechanisms in chroma- analysis despite the anticipated poor precision. The experimen- tography was quantitatively achieved using molecular mechan- tally measured dissociation of phenolphthalein is described ics and MOPAC programs [1]. Furthermore, the reaction mech- using four dissociation structures, where the ionization of two anisms of highly sensitive detections were also quantitatively phenolic hydroxyl groups converts the neutral molecular form described [2,3].
  • Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood

    Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 11 June 2019 doi:10.20944/preprints201906.0091.v1 Peer-reviewed version available at Biomolecules 2019, 9; doi:10.3390/biom9040123 Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood Abheepsa Mishra1, 2,* and Satyahari Dey1 1Plant Biotechnology Laboratory, Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur-721302, West Bengal, India; [email protected] (A.M.); [email protected] (S.D.) 2Department of Internal Medicine, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA *Correspondence: [email protected]; Tel.:+1(518) 881-9196 Abstract Natural products from plants such as, chemopreventive agents attract huge attention because of their low toxicity and high specificity. The rational drug design in combination with structure based modeling and rapid screening methods offer significant potential for identifying and developing lead anticancer molecules. Thus, the molecular docking method plays an important role in screening a large set of molecules based on their free binding energies and proposes structural hypotheses of how the molecules can inhibit the target. Several peptide based therapeutics have been developed to combat several health disorders including cancers, metabolic disorders, heart-related, and infectious diseases. Despite the discovery of hundreds of such therapeutic peptides however, only few peptide-based drugs have made it to the market. Moreover, until date the activities of cyclic peptides towards molecular targets such as protein kinases, proteases, and apoptosis related proteins have never been explored. In this study we explore the in silico kinase and protease inhibitor potentials of cyclosaplin as well as study the interactions of cyclosaplin with other cancer-related proteins.
  • BIOVIA DISCOVERY STUDIO® 2016 COMPREHENSIVE MODELING and SIMULATIONS for LIFE SCIENCES Datasheet

    BIOVIA DISCOVERY STUDIO® 2016 COMPREHENSIVE MODELING and SIMULATIONS for LIFE SCIENCES Datasheet

    BIOVIA DISCOVERY STUDIO® 2016 COMPREHENSIVE MODELING AND SIMULATIONS FOR LIFE SCIENCES Datasheet ACCURATELY Drug discovery is a multi-objective optimization. Scientists have to optimize both biochemical potency and characteristics such as ADME and toxicity. The latest PREDICT LIGAND release of BIOVIA’s predictive science application, Discovery Studio®, continues the BINDING evolution of new science in its market-leading CHARMm molecular simulations engine. Built on BIOVIA Foundation™, Discovery Studio® is uniquely positioned as ENERGIES the most comprehensive, collaborative modeling and simulation application for Life Sciences discovery research. DISCOVERY STUDIO 2016 Part of the 2016 BIOVIA product release series, Discovery Studio 2016 continues to deliver key new CHARMm-based molecular simulations. NEW AND ENHANCED SCIENCE • New! Steered Molecular Dynamics: Developed and validated in academia by members of the CHARMM Developer community2,3, the CHARMM AFM (Atomic Force Microscopy) function has been included in the latest release of Discovery Studio CHARMm • Apply a pull force to a molecular system to: • Estimate the ligand binding free energy • Study the conformational details of the ligand unbinding process • Investigate protein unfolding or conformational • Major DMol3 Performance Improvement: The latest release changes of the density functional theory program DMol3, version • Two protocols have been included to enable the simulation 2016, includes dramatic performance improvements, both in of protein or protein-ligand complexes while
  • UCSF Chimera Was Developed by the Computer Graphics Laboratory at the University of California, San Francisco, Under Support of NIH Grant P41-RR01081

    UCSF Chimera Was Developed by the Computer Graphics Laboratory at the University of California, San Francisco, Under Support of NIH Grant P41-RR01081

    matrixcopy apply the transformation matrix of one model to another tcolor color using texture map colors UCSF Chimera matrixget write the current transformation matrices to a ®le texture de®ne texture maps and associated colors QUICK REFERENCE GUIDE June 2007 matrixset read and apply transformation matrices from a ®le thickness move the clipping planes in opposite directions minimize energy-minimize structures turn rotate about the X, Y, or Z axis mmaker (matchmaker) align models in sequence, then in 3D vdw* display van der Waals (VDW) surface modelcolor set color at the model level vdwde®ne* set VDW radii Commands modeldisplay* set display at the model level vdwdensity set VDW surface dot density *reverse function Äcommand available move translate along the X, Y, or Z axis version show copyright information and Chimera version movie capture image frames and assemble them into a movie viewdock start ViewDock and load docking results 2dlabels create arbitrary text labels and place them in 2D namesel name and save the current selection wait suspend command processing until motion has stopped ac enable accelerators (keyboard shortcuts) neon create a shadowed stick/tube image (not on Windows) window adjust the view to contain the speci®ed atoms addaa add an amino acid to a peptide C-terminus objdisplay* display graphical objects windowsize adjust the dimensions of the graphics window addcharge assign partial charges to atoms open* read structures and data, execute command ®les write save a molecule model as a PDB ®le addh add hydrogens pdbrun
  • In Silico Screening and Molecular Docking of Bioactive Agents Towards Human Coronavirus Receptor

    In Silico Screening and Molecular Docking of Bioactive Agents Towards Human Coronavirus Receptor

    GSC Biological and Pharmaceutical Sciences, 2020, 11(01), 132–140 Available online at GSC Online Press Directory GSC Biological and Pharmaceutical Sciences e-ISSN: 2581-3250, CODEN (USA): GBPSC2 Journal homepage: https://www.gsconlinepress.com/journals/gscbps (RESEARCH ARTICLE) In silico screening and molecular docking of bioactive agents towards human coronavirus receptor Pratyush Kumar *, Asnani Alpana, Chaple Dinesh and Bais Abhinav Priyadarshini J. L. College of Pharmacy, Electronic Building, Electronic Zone, MIDC, Hingna Road, Nagpur-440016, Maharashtra, India. Publication history: Received on 09 April 2020; revised on 13 April 2020; accepted on 15 April 2020 Article DOI: https://doi.org/10.30574/gscbps.2020.11.1.0099 Abstract Coronavirus infection has turned into pandemic despite of efforts of efforts of countries like America, Italy, China, France etc. Currently India is also outraged by the virulent effect of coronavirus. Although World Health Organisation initially claimed to have all controls over the virus, till date infection has coasted several lives worldwide. Currently we do not have enough time for carrying out traditional approaches of drug discovery. Computer aided drug designing approaches are the best solution. The present study is completely dedicated to in silico approaches like virtual screening, molecular docking and molecular property calculation. The library of 15 bioactive molecules was built and virtual screening was carried towards the crystalline structure of human coronavirus (6nzk) which was downloaded from protein database. Pyrx virtual screening tool was used and results revealed that F14 showed best binding affinity. The best screened molecule was further allowed to dock with the target using Autodock vina software.